SCHEMBL6201657

SCHEMBL6201657

O=C(Cl)c1cccc(Oc2ccncc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.54
TNKS O95271 1/20 0.50
PARP15 Q460N3 1/20 0.50
PARP14 Q460N5 1/20 0.50
PARP10 Q53GL7 1/20 0.50
TNKS2 Q9H2K2 1/20 0.50
PARP2 Q9UGN5 1/20 0.50
HDAC8 Q9BY41 1/20 0.49
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KMO O15229 1/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RAF1 P04049 1/20 0.45
NPC1 O15118 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL726592 0.88 AKR1C3 (0.62) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL1193379 0.86 AKR1C3 (0.72) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL10933601 0.86 AKR1C3 (0.60) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL6200942 0.85 AKR1C3 (0.77) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL10782197 0.84 AKR1C3 (0.70) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL7742691 0.84 PARP10 (0.64) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL727287 0.84 PARP10 (0.64) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL6202616 0.84 LMNA (0.64) KDM4ELMNAGRM5
Hydrochloric Acid SCHEMBL6199364 0.83 AKR1C3 (0.74) AKR1C3TNKSPARP15PARP14PARP10
SCHEMBL10496906 0.81 TNKS (0.60) AKR1C3TNKSPARP15PARP14PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed